GemPharmatech (SH:688046) Xin Lang Cai Jing·2026-01-09 07:15Group 1 - Jiangsu Jicui Yaokang Biotechnology Co., Ltd. specializes in the research, production, and sales of laboratory mouse models and related technical services, with a total market value of 7.249 billion yuan as of January 9 [1] - The company's main business revenue composition includes: commercial mouse model sales (55.36%), functional efficacy (23.46%), custom breeding (11.32%), model creation (7.06%), and import-export agency and others (2.70%) [1] - As of January 9, Yaokang's stock price increased by 5.05% to 17.68 yuan per share, with a trading volume of 77.5669 million yuan and a turnover rate of 1.10% [1] Group 2 - The top circulating shareholder of Yaokang is the Nuoan Fund, which reduced its holdings in the Nuoan Pioneer Mixed A Fund (320003) by 265,200 shares, now holding 5.0687 million shares, accounting for 1.24% of circulating shares [2] - The Nuoan Pioneer Mixed A Fund has achieved a year-to-date return of 7.4% and a one-year return of 48.16%, ranking 661 out of 8,827 and 2,116 out of 8,084 respectively [2] - The fund manager, Yang Gu, has a tenure of 19 years and 327 days, with the fund's total asset size at 5.804 billion yuan and a best return of 1,088.72% during his tenure [3]